0001209191-23-007367.txt : 20230206
0001209191-23-007367.hdr.sgml : 20230206
20230206190330
ACCESSION NUMBER: 0001209191-23-007367
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230203
FILED AS OF DATE: 20230206
DATE AS OF CHANGE: 20230206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DENYES NANCY
CENTRAL INDEX KEY: 0001640869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 23592137
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER NAME:
FORMER CONFORMED NAME: Krueger Nancy
DATE OF NAME CHANGE: 20150429
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-03
0
0001339970
aTYR PHARMA INC
LIFE
0001640869
DENYES NANCY
3545 JOHN HOPKINS COURT, SUITE 250
SAN DIEGO
CA
92121
0
1
0
0
General Counsel
Common stock
2023-02-03
4
M
0
2688
A
7079
D
Restricted Stock Unit
2023-02-03
4
M
0
2688
0.00
D
Common Stock
2688
8062
D
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.
Restricted stock units convert into common stock on a one-for-one basis.
Includes 944 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 15, 2022.
The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
/s/ Nancy E. Denyes
2023-02-06